quotable quotes - April 2014
“You could be buying a pretty decent A1c with a series of highs and lows. That affects patients every single day. Diabetics dance with the devil every single day… It’s very, very frustrating. The message is that patients are failing. But it’s not that patients are failing. It is patients being failed by their treatment options.”
-Patient representative Ms. Rebecca Killion reflects on the value of MannKind’s Afrezza (inhaled ultra-rapid-acting insulin) in type 1 diabetes at the FDA Advisory Committee on April 1, 2014 in Hyattsville, MD.
“Patients with diabetes walk a tightrope every day, balancing the risk of short-term hypoglycemia with the long-term consequences of high blood sugars. Anything we can do to help patients walk that tight rope more confidently is huge.”
-Managing Editor of diaTribe Adam Brown speaks on the impact Afrezza could have on the lives of people with diabetes at the FDA Advisory Committee.
“Insulin was associated with ~97,000 ER visits and ~29,000 hospital admissions each year in 2007-2011. To put this in perspective, methamphetamine resulted in 93,000 ER visits. That insulin beats Breaking Bad is evidence that real word solutions are needed.”
-Mr. Bennet Dunlap (Strip Safely) highlighting the very real dangers of taking insulin at the FDA Advisory Committee on Afrezza.
“When my patients go home with CGM, they learn things that I couldn’t tell them with three months of education, since they can see the data themselves.”
-Dr. Timothy S. Bailey of the AMCR Institute at the 10th Annual Clinical Diabetes Technology Meeting (CDTM 2014), April 4-5, 2014 in Los Angeles, CA.
"We do need to address the issue of shame and this cultural stigma that promotes the idea that you have to be ashamed of an illness...We have to get away from moral condemnation and phrases like ‘good sugar, bad sugar, good patients, and bad patients.’”
-Dr. Marilyn Ritzholz of the Joslin Diabetes Center at CDTM 2014.
Looking for more great quotes? Please read our open letter to the New York Times, with quotes from industry leaders, patient advocates, and diabetes experts on the importance of diabetes innovation.
Never miss an update by signing up here to receive free updates on future diaTribe articles.
